Literature DB >> 9146009

Epithelial coating techniques in the treatment of interstitial cystitis.

C L Parsons1.   

Abstract

OBJECTIVES: To review the newer methods of treatment of interstitial cystitis using techniques that coat the epithelium to maintain its integrity relative to permeability.
METHODS: The technique of employing sulfated polysaccharides in the treatment of interstitial cystitis both orally and intravesically were reviewed as well as the concepts supporting the use of such technology, including a review of the role glycosaminoglycans (mucus) play in the regulation of epithelial permeability. Also reviewed were the methods that can be employed to detect aberrations of epithelial permeability as seen in the interstitial cystitis syndrome.
RESULTS: The techniques of detecting epithelial permeability problems and appropriate therapy for this using polysaccharides, such as heparin and pentosanpolysulfate, are presented. This article also discusses the point that these techniques will result in long-term remissions in patients with the IC syndrome who respond to these treatments.
CONCLUSIONS: The use of sulfated polysaccharides, both orally and intravesically, is an effective long-term treatment for many people with the interstitial cystitis syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146009     DOI: 10.1016/s0090-4295(97)00180-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

2.  Interstitial cystitis and lower urinary tract symptoms in males and females-the combined role of potassium and epithelial dysfunction.

Authors:  C Lowell Parsons
Journal:  Rev Urol       Date:  2002

3.  Hyaluronic Acid and Chondroitin Sulphate Treatment for Recurrent Severe Urinary Tract Infections due to Multidrug-Resistant Gram-Negative Bacilli in a Patient With Multiple Sclerosis: Case Report and Literature Review.

Authors:  Aurélien Dinh; Clara Duran; Kamel Hamami; Muriel Afif; Francine Bonnet; Jean-Luc Donay; Matthieu Lafaurie; Emmanuel Chartier-Kastler
Journal:  Open Forum Infect Dis       Date:  2022-05-12       Impact factor: 4.423

4.  Efficacy and safety of pirarubicin combined with hyaluronic acid for non-muscle invasive bladder cancer after transurethral resection: a prospective, randomized study.

Authors:  Weiping Huang; Feng Wang; Cunzao Wu; Weilie Hu
Journal:  Int Urol Nephrol       Date:  2015-03-12       Impact factor: 2.370

5.  Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

Authors:  Paul J Hauser; David A Buethe; John Califano; Troy M Sofinowski; Daniel J Culkin; Robert E Hurst
Journal:  J Urol       Date:  2009-09-17       Impact factor: 7.450

6.  Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.

Authors:  Davide De Vita; Henrik Antell; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

7.  Molecular size affects urine excretion of pentosan polysulfate.

Authors:  Deborah R Erickson; Mostafa Sheykhnazari; Veer P Bhavanandan
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

8.  Intravesical instillations for the treatment of refractory recurrent urinary tract infections.

Authors:  Sonia Dutta; Felicia Lane
Journal:  Ther Adv Urol       Date:  2018-02-18

9.  Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation.

Authors:  Tingsheng Lin; Xiaozhi Zhao; Yifan Zhang; Huibo Lian; Junlong Zhuang; Qing Zhang; Wei Chen; Wei Wang; Guangxiang Liu; Suhan Guo; Jinhui Wu; Yiqiao Hu; Hongqian Guo
Journal:  Materials (Basel)       Date:  2016-12-12       Impact factor: 3.623

Review 10.  Current investigations and treatment of interstitial cystitis.

Authors:  A E Gousse; R Tiguert; S Madjar
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.